On september 11, 2020, stimwave's chief medical officer (cmo) reviewed the event.Cmo requested patient contact information and recommended x-rays.X-rays have not been confirmed to have been taken or provided at this time.Cr reported that patient had lost therapy prior to the mri scan, potentially indicating migration.The stimulator was reported to meet product specifications.Device can not currently be received by manufacturer for analysis.The device was used for treatment of pain.The cause of the reported event could not be determined with the information available during the investigation.
|